168 related articles for article (PubMed ID: 3057965)
21. Angiotensin-converting enzyme in the human nasal mucosa.
Ohkubo K; Lee CH; Baraniuk JN; Merida M; Hausfeld JN; Kaliner MA
Am J Respir Cell Mol Biol; 1994 Aug; 11(2):173-80. PubMed ID: 8049077
[TBL] [Abstract][Full Text] [Related]
22. Allergic rhinitis, olfactory disorders and secretory IgA.
Paparo BS; Leri O; Andreoli P; Arcai Chirra A; Casagrande M; Addessi MA; Sagnelli P; De Rosa FG; Sagnelli M
Riv Eur Sci Med Farmacol; 1996; 18(4):157-61. PubMed ID: 9177615
[TBL] [Abstract][Full Text] [Related]
23. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
[TBL] [Abstract][Full Text] [Related]
24. Human nasal glandular secretion of novel antioxidant activity: cholinergic control.
Peden DB; Brown ME; Wade Y; Raphael GD; Berkebile C; Kaliner MA
Am Rev Respir Dis; 1991 Mar; 143(3):545-52. PubMed ID: 2001065
[TBL] [Abstract][Full Text] [Related]
25. Distribution of secretory leukoprotease inhibitor in the human nasal airway.
Lee CH; Igarashi Y; Hohman RJ; Kaulbach H; White MV; Kaliner MA
Am Rev Respir Dis; 1993 Mar; 147(3):710-6. PubMed ID: 8095126
[TBL] [Abstract][Full Text] [Related]
26. Mucosal immunity in allergic rhinitis.
Cortesina G; Carlevato MT; Bussi M; Baldi C; Majore L; Ruffino C
Acta Otolaryngol; 1993 May; 113(3):397-9. PubMed ID: 8517145
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of polymeric immunoglobulin receptor and secretory IgA antibodies in eosinophilic upper airway diseases.
Hupin C; Rombaux P; Bowen H; Gould H; Lecocq M; Pilette C
Allergy; 2013 Dec; 68(12):1589-97. PubMed ID: 24117840
[TBL] [Abstract][Full Text] [Related]
28. Non-specific rhinoreactivity: non-specific nasal provocation tests with methacholine and cold water solution.
Filiaci F; Zambetti G; Di Filippo S; Mancini CM
Allergol Immunopathol (Madr); 1985; 13(1):29-34. PubMed ID: 3890498
[TBL] [Abstract][Full Text] [Related]
29. The sources of chemical substances in allergic nasal fluid.
Ichikawa K; Okuda M; Naka F; Yago H
Rhinology; 1991 Jun; 29(2):143-9. PubMed ID: 1716374
[TBL] [Abstract][Full Text] [Related]
30. Local application of atropine attenuates the upper airway reaction to cold, dry air.
Cruz AA; Togias AG; Lichtenstein LM; Kagey-Sobotka A; Proud D; Naclerio RM
Am Rev Respir Dis; 1992 Aug; 146(2):340-6. PubMed ID: 1489122
[TBL] [Abstract][Full Text] [Related]
31. Duration of action of intranasal atropine on methacholine-induced nasal secretions.
Baroody FM; Driscoll PV; Moylan B; Fleming L; Shilstone J; Naclerio RM
Arch Otolaryngol Head Neck Surg; 1996 Mar; 122(3):321-3. PubMed ID: 8607961
[TBL] [Abstract][Full Text] [Related]
32. The concentrations of IgA and free secretory piece in the nasal secretions of patients with recurrent respiratory infections.
Stanley PJ; Cole PJ
Clin Exp Immunol; 1985 Jan; 59(1):197-202. PubMed ID: 3918818
[TBL] [Abstract][Full Text] [Related]
33. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
[TBL] [Abstract][Full Text] [Related]
34. Effects of capsaicin desensitization on nasal mucosal secretion in guinea pigs in vivo.
Gawin AZ; Baraniuk JN; Igarashi Y; Kaliner MA
J Appl Physiol (1985); 1993 Aug; 75(2):798-804. PubMed ID: 8226484
[TBL] [Abstract][Full Text] [Related]
35. The influence of neuropharmaca on the nasal glands. Preliminary report.
Klaassen AB; Kuijpers W; Rodrigues de Miranda JF; Beld AJ
Rhinology; 1985 Sep; 23(3):191-4. PubMed ID: 3903958
[TBL] [Abstract][Full Text] [Related]
36. Viscosity and spinability of nasal secretions induced by different provocation tests.
Brofeldt S; Mygind N
Am Rev Respir Dis; 1987 Aug; 136(2):353-6. PubMed ID: 3304045
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin concentrations in nasal secretions differ between patients with an IgE-mediated rhinopathy and a non-IgE-mediated rhinopathy.
Swart SJ; van der Baan S; Steenbergen JJ; Nauta JJ; van Kamp GJ; Biewenga J
J Allergy Clin Immunol; 1991 Oct; 88(4):612-9. PubMed ID: 1918727
[TBL] [Abstract][Full Text] [Related]
38. Human nasal mucosal neutral endopeptidase (NEP): location, quantitation, and secretion.
Ohkubo K; Baraniuk JN; Hohman RJ; Kaulbach HC; Hausfeld JN; Merida M; Kaliner MA
Am J Respir Cell Mol Biol; 1993 Nov; 9(5):557-67. PubMed ID: 8217197
[TBL] [Abstract][Full Text] [Related]
39. Lateral nasal gland secretion in the anesthetized ferret.
Mizoguchi H; Widdicombe JG
J Appl Physiol (1985); 1989 Dec; 67(6):2553-5. PubMed ID: 2481668
[TBL] [Abstract][Full Text] [Related]
40. The effects of autonomotropic drugs on allergic nasal mucosa.
Watase T; Okuda M
Rhinology; 1986 Sep; 24(3):181-6. PubMed ID: 2946068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
